ARTICLE | Clinical News
Skeletal Targeted Radiotherapy (STR): Began Phase I trial
March 27, 2000 8:00 AM UTC
NeoRx Corp. (NERX), Seattle, Wash. Product: Skeletal Targeted Radiotherapy (STR) Business: Cancer Therapeutic category: Cytotoxic Target: Bone cells Description: Radiolabeled bone-targeting small mole...